This is a Validated Antibody Database (VAD) review about bovine YAP1, based on 59 published articles (read how Labome selects the articles), using YAP1 antibody in all methods. It is aimed to help Labome visitors find the most suited YAP1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on human samples at 1:1000 (fig 4a). elife (2019) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on mouse samples at 1:500 (fig 4d). Exp Mol Med (2018) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 11
Cell Signaling Technology YAP1 antibody (Cell Signaling Technologies, 4911) was used in western blot on human samples at 1:1000 (fig 11). PLoS Pathog (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5a). J Gynecol Oncol (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 1a). PLoS Biol (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911S) was used in western blot on human samples at 1:1000 (fig 5c). Cell Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d, 5f
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in western blot on human samples (fig 4d, 5f). Cells (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1s2b, 1s3a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 1s2b, 1s3a). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7b
Cell Signaling Technology YAP1 antibody (CST, 4911) was used in western blot on mouse samples at 1:1000 (fig 7b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911S) was used in western blot on human samples (fig 7b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4d
Cell Signaling Technology YAP1 antibody (CST, 4911S) was used in western blot on mouse samples (fig 4d). Science (2019) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on human samples at 1:1000 (fig 4a). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 3b). Biomolecules (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3b, 3j
Cell Signaling Technology YAP1 antibody (CST, 4911) was used in western blot on human samples at 1:1000 (fig 3b, 3j). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 1c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:500 (fig 1c). Stem Cells (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 3a). Cancer Manag Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 8a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 8a). PLoS Biol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 3a). J Clin Invest (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in western blot on human samples (fig 1f). Curr Biol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 1b
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:500 (fig 1b). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 5c). J Cell Sci (2018) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on mouse samples at 1:500 (fig 4d). Exp Mol Med (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 8c). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2a). Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1fs2
In order to test the role of YAP in branching morphogenesis for tissue patterning, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry on mouse samples at 1:100 (fig 1fs2). elife (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology YAP1 antibody (CST, 4911) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4e
In order to find that that Fat4 modulates Hippo signaling and restricts hearth growth in mice, Cell Signaling Technology YAP1 antibody (Cell signalling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4e). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
In order to find that frictional force characteristic of flow in the lymphatics stimulates YAP1 to drive cancer cell migration, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 3c). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 3b
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on mouse samples at 1:500 (fig 3b). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4a
In order to report that DUB3 family deubiquitylating enzymes regulate Hippo pathway activity, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 3a
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on mouse samples at 1:500 (fig 3a) and in western blot on human samples at 1:1000 (fig 3b). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 1i
  • western blot; mouse; 1:1000; loading ...; fig 1b
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 1i) and in western blot on mouse samples at 1:1000 (fig 1b). Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 1a). Cell (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2f
In order to demonstrate that the Hippo, Wnt/beta-catenin, and Notch pathways interact to regulate liver size and inhibit hepatocellular carcinoma, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s2f). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 1g
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 1g) and in western blot on human samples at 1:1000 (fig 1a). Gastroenterology (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5h
Cell Signaling Technology YAP1 antibody (cell signalling, 4911) was used in western blot on human samples (fig 5h). J Clin Invest (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:100 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5A
In order to explore the role of NHERF1 in intestinal adenoma development, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5A). Neoplasia (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 2
  • western blot; human; fig 2
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 2) and in western blot on human samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 4e
  • western blot; rat; loading ...; fig 4c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 4e) and in western blot on rat samples (fig 4c). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:150; fig 6
  • western blot; mouse; 1:2000; fig s3
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry on mouse samples at 1:150 (fig 6) and in western blot on mouse samples at 1:2000 (fig s3). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4
In order to investigate mechanisms that regulate myelin growth and nerve conduction, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7g
In order to study interaction between the p38 mitogen-activated protein kinase pathway and the Hippo pathway, Cell Signaling Technology YAP1 antibody (Cell Signalling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 7g). J Mol Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7c
In order to investigate the contribution of YAP in mouse neocortical astrocytic differentiation and proliferation, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 7c). Development (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3d
  • western blot; rat; 1:1000; loading ...; fig 3d
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 3d) and in western blot on rat samples at 1:1000 (fig 3d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples (fig 1). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
In order to study the production of a dominantly-acting oncogene in human breast cancer due to premature polyadenylation of MAGI3, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; chicken; 1:1000; fig 7
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in western blot on chicken samples at 1:1000 (fig 7). BMC Biol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 5
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911S) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 5). Front Physiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
In order to study GSK3 inhibitor BIS I, YAP-dependent EMT signature in PDAC cell lines, and SMADs expression level, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 5
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 5). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples at 1:1000 (fig 1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:50; fig 6
  • immunocytochemistry; mouse; 1:50; fig 6
In order to report that NEK8 human mutations cause major organ developmental defects, altered ciliogenesis, disrupted cell differentiation and proliferation, and deregulation of the Hippo pathway, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in immunocytochemistry on human samples at 1:50 (fig 6) and in immunocytochemistry on mouse samples at 1:50 (fig 6). PLoS Genet (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to investigate Tead4-mediated transcriptional networks in various types of cancer cells, Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples (fig 4). Cell Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4
  • western blot; human; fig 7
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 4) and in western blot on human samples (fig 7). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to study the activation mechanisms of core Hippo pathway components, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples (fig 3). EMBO Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000. Oncogene (2016) ncbi
Articles Reviewed
  1. Van Sciver N, Ohashi M, Pauly N, Bristol J, Nelson S, JOHANNSEN E, et al. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathog. 2021;17:e1009783 pubmed publisher
  2. Xiao L, Shi X, Li Z, Li M, Zhang M, Yan S, et al. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway. J Gynecol Oncol. 2021;32:e77 pubmed publisher
  3. Mia M, Cibi D, Abdul Ghani S, Song W, Tee N, Ghosh S, et al. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol. 2020;18:e3000941 pubmed publisher
  4. Seo G, Han H, Vargas R, Yang B, Li X, Wang W. MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation. Cell Rep. 2020;32:107860 pubmed publisher
  5. Rigiracciolo D, Nohata N, Lappano R, Cirillo F, Talia M, Scordamaglia D, et al. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells. 2020;9: pubmed publisher
  6. Bae S, Ni L, Luo X. STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism. elife. 2020;9: pubmed publisher
  7. Zhou T, Gao B, Fan Y, Liu Y, Feng S, Cong Q, et al. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin. elife. 2020;9: pubmed publisher
  8. Kim J, Berrios C, Kim M, SCHADE A, Adelmant G, Yeerna H, et al. STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells. elife. 2020;9: pubmed publisher
  9. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  10. Zeng H, Castillo Cabrera J, Manser M, Lu B, Yang Z, Strande V, et al. Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. elife. 2019;8: pubmed publisher
  11. Zhou L, Wang Q, Zhang H, Li Y, Xie S, Xu M. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine. Biomolecules. 2019;9: pubmed publisher
  12. Park M, Kim A, Manandhar S, Oh S, Jang G, Kang L, et al. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. elife. 2019;8: pubmed publisher
  13. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  14. Rong X, Han Q, Lin X, Kremerskothen J, Wang E. FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells. Cancer Manag Res. 2019;11:3395-3410 pubmed publisher
  15. Miller C, Lou H, Simpson C, van de Kooij B, Ha B, Fisher O, et al. Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output. PLoS Biol. 2019;17:e2006540 pubmed publisher
  16. Li B, He J, Lv H, Liu Y, Lv X, Zhang C, et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. J Clin Invest. 2019;129:1167-1179 pubmed publisher
  17. Rausch V, Bostrom J, Park J, Bravo I, Feng Y, Hay D, et al. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae. Curr Biol. 2019;29:242-255.e6 pubmed publisher
  18. Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton B, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9:2269 pubmed publisher
  19. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  20. Ibar C, Kirichenko E, Keepers B, Enners E, Fleisch K, Irvine K. Tension-dependent regulation of mammalian Hippo signaling through LIMD1. J Cell Sci. 2018;131: pubmed publisher
  21. Lu L, Finegold M, Johnson R. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med. 2018;50:e423 pubmed publisher
  22. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  23. Toloczko A, Guo F, Yuen H, Wen Q, Wood S, Ong Y, et al. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Cancer Res. 2017;77:4921-4933 pubmed publisher
  24. Lin C, Yao E, Zhang K, Jiang X, Croll S, Thompson Peer K, et al. YAP is essential for mechanical force production and epithelial cell proliferation during lung branching morphogenesis. elife. 2017;6: pubmed publisher
  25. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  26. Ragni C, Diguet N, Le Garrec J, Novotova M, Resende T, Pop S, et al. Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth. Nat Commun. 2017;8:14582 pubmed publisher
  27. Lee H, Diaz M, Price K, Ozuna J, Zhang S, Sevick Muraca E, et al. Fluid shear stress activates YAP1 to promote cancer cell motility. Nat Commun. 2017;8:14122 pubmed publisher
  28. Hirai M, Arita Y, McGlade C, Lee K, Chen J, Evans S. Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest. 2017;127:569-582 pubmed publisher
  29. Nguyen H, Kugler J, Cohen S. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins. PLoS ONE. 2017;12:e0169587 pubmed publisher
  30. Jerić I, Maurer G, Cavallo A, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7:13781 pubmed publisher
  31. Wang L, Luo J, Li B, Tian X, Chen L, Huang Y, et al. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature. 2016;540:579-582 pubmed publisher
  32. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  33. Kim W, Khan S, Gvozdenovic Jeremic J, Kim Y, Dahlman J, Kim H, et al. Hippo signaling interactions with Wnt/?-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137-152 pubmed publisher
  34. Kim H, Kim M, Park Y, Park I, Kim T, Yang S, et al. Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice. Gastroenterology. 2017;152:616-630 pubmed publisher
  35. Matsumoto Y, La Rose J, Kent O, Wagner M, Narimatsu M, Levy A, et al. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. J Clin Invest. 2016;126:4482-4496 pubmed publisher
  36. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  37. Georgescu M, Gagea M, Cote G. NHERF1/EBP50 Suppresses Wnt-?-Catenin Pathway-Driven Intestinal Neoplasia. Neoplasia. 2016;18:512-23 pubmed publisher
  38. Vahid S, Thaper D, Gibson K, Bishop J, Zoubeidi A. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer. Sci Rep. 2016;6:31842 pubmed publisher
  39. Ruess D, Probst M, Marjanovic G, Wittel U, Hopt U, Keck T, et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS ONE. 2016;11:e0161233 pubmed publisher
  40. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  41. Fernando R, Cotter L, Perrin Tricaud C, Berthelot J, Bartolami S, Pereira J, et al. Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. Nat Commun. 2016;7:12186 pubmed publisher
  42. Huang D, Li X, Sun L, Huang P, Ying H, Wang H, et al. Regulation of Hippo signalling by p38 signalling. J Mol Cell Biol. 2016;8:328-37 pubmed publisher
  43. Feng X, Liu P, Zhou X, Li M, Li F, Wang Z, et al. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration. J Biol Chem. 2016;291:18947-58 pubmed publisher
  44. Huang Z, Hu J, Pan J, Wang Y, Hu G, Zhou J, et al. YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation. Development. 2016;143:2398-409 pubmed publisher
  45. Simile M, Latte G, Demartis M, Brozzetti S, Calvisi D, Porcu A, et al. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. Oncotarget. 2016;7:49194-49216 pubmed publisher
  46. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  47. Ni T, Kuperwasser C. Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer. elife. 2016;5: pubmed publisher
  48. McKey J, Martire D, de Santa Barbara P, Faure S. LIX1 regulates YAP1 activity and controls the proliferation and differentiation of stomach mesenchymal progenitors. BMC Biol. 2016;14:34 pubmed publisher
  49. Lodge E, Russell J, Patist A, Francis West P, Andoniadou C. Expression Analysis of the Hippo Cascade Indicates a Role in Pituitary Stem Cell Development. Front Physiol. 2016;7:114 pubmed publisher
  50. Thongon N, Castiglioni I, Zucal C, Latorre E, D Agostino V, Bauer I, et al. The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level. Oncotarget. 2016;7:26551-66 pubmed publisher
  51. Keyvani Chahi A, Martin C, Jones N. Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP. J Biol Chem. 2016;291:12799-808 pubmed publisher
  52. Ma B, Cheng H, Gao R, Mu C, Chen L, Wu S, et al. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Nat Commun. 2016;7:11123 pubmed publisher
  53. Grampa V, Delous M, Zaidan M, Odye G, Thomas S, Elkhartoufi N, et al. Novel NEK8 Mutations Cause Severe Syndromic Renal Cystic Dysplasia through YAP Dysregulation. PLoS Genet. 2016;12:e1005894 pubmed publisher
  54. Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498 pubmed publisher
  55. Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J, et al. Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016;14:1169-1180 pubmed publisher
  56. Dai X, Zhuang L, Wang D, Zhou T, Chang L, Gai R, et al. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells. Oncotarget. 2016;7:6933-47 pubmed publisher
  57. Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, et al. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A. 2016;113:E71-80 pubmed publisher
  58. Kim M, Kim M, Park S, Lee C, Lim D. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep. 2016;17:64-78 pubmed publisher
  59. Tanas M, Ma S, Jadaan F, Ng C, Weigelt B, Reis Filho J, et al. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein. Oncogene. 2016;35:929-38 pubmed publisher